186 related articles for article (PubMed ID: 23939557)
1. [Pharmacological treatment for patients with borderline personality disorder: practice and study results].
Schwerthöffer D; Bäuml J; Rentrop M
Fortschr Neurol Psychiatr; 2013 Aug; 81(8):437-43. PubMed ID: 23939557
[TBL] [Abstract][Full Text] [Related]
2. Meta-analyses of mood stabilizers, antidepressants and antipsychotics in the treatment of borderline personality disorder: effectiveness for depression and anger symptoms.
Mercer D; Douglass AB; Links PS
J Pers Disord; 2009 Apr; 23(2):156-74. PubMed ID: 19379093
[TBL] [Abstract][Full Text] [Related]
3. A naturalistic study of changes in pharmacological prescription for borderline personality disorder in clinical practice: from APA to NICE guidelines.
Pascual JC; Martín-Blanco A; Soler J; Ferrer A; Tiana T; Alvarez E; Pérez V
Int Clin Psychopharmacol; 2010 Nov; 25(6):349-55. PubMed ID: 20838221
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological treatments for personality disorders.
Paris J
Int Rev Psychiatry; 2011 Jun; 23(3):303-9. PubMed ID: 21923229
[TBL] [Abstract][Full Text] [Related]
5. Pharmacotherapy for borderline personality disorder--current evidence and recent trends.
Stoffers JM; Lieb K
Curr Psychiatry Rep; 2015 Jan; 17(1):534. PubMed ID: 25413640
[TBL] [Abstract][Full Text] [Related]
6. Differential effectiveness of antipsychotics in borderline personality disorder: meta-analyses of placebo-controlled, randomized clinical trials on symptomatic outcome domains.
Ingenhoven TJ; Duivenvoorden HJ
J Clin Psychopharmacol; 2011 Aug; 31(4):489-96. PubMed ID: 21694626
[TBL] [Abstract][Full Text] [Related]
7. Clinical psychopharmacology of borderline personality disorder: an update on the available evidence in light of the Diagnostic and Statistical Manual of Mental Disorders - 5.
Ripoll LH
Curr Opin Psychiatry; 2012 Jan; 25(1):52-8. PubMed ID: 22037092
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacological treatment of borderline personality disorders. Several options for symptom reduction but nothing for the disorder per se].
Rydén G; Vinnars B
Lakartidningen; 2002 Dec; 99(50):5088-94. PubMed ID: 12572301
[TBL] [Abstract][Full Text] [Related]
9. Pharmacotherapy of borderline states.
Brinkley JR
Psychiatr Clin North Am; 1993 Dec; 16(4):853-84. PubMed ID: 7906031
[TBL] [Abstract][Full Text] [Related]
10. Association of pharmacological treatments and real-world outcomes in borderline personality disorder.
Lieslehto J; Tiihonen J; Lähteenvuo M; Mittendorfer-Rutz E; Tanskanen A; Taipale H
Acta Psychiatr Scand; 2023 Jun; 147(6):603-613. PubMed ID: 37094828
[TBL] [Abstract][Full Text] [Related]
11. Antipsychotics, antidepressants, anticonvulsants, and placebo on the symptom dimensions of borderline personality disorder: a meta-analysis of randomized controlled and open-label trials.
Vita A; De Peri L; Sacchetti E
J Clin Psychopharmacol; 2011 Oct; 31(5):613-24. PubMed ID: 21869691
[TBL] [Abstract][Full Text] [Related]
12. Psychopharmacology of borderline personality disorder.
Raj YP
Curr Psychiatry Rep; 2004 Jun; 6(3):225-31. PubMed ID: 15142476
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological Management of Borderline Personality Disorder and Common Comorbidities.
Pascual JC; Arias L; Soler J
CNS Drugs; 2023 Jun; 37(6):489-497. PubMed ID: 37256484
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacotherapy effectiveness for some symptoms of borderline personality disorder].
Benjaminsen S
Ugeskr Laeger; 2014 Sep; 176(36):. PubMed ID: 25293847
[TBL] [Abstract][Full Text] [Related]
15. Current and emerging medications for borderline personality disorder: is pharmacotherapy alone enough?
Bozzatello P; Rocca P; De Rosa ML; Bellino S
Expert Opin Pharmacother; 2020 Jan; 21(1):47-61. PubMed ID: 31693423
[No Abstract] [Full Text] [Related]
16. The interface between borderline personality disorder and bipolar spectrum disorders.
Paris J; Gunderson J; Weinberg I
Compr Psychiatry; 2007; 48(2):145-54. PubMed ID: 17292705
[TBL] [Abstract][Full Text] [Related]
17. Update on pharmacotherapy of borderline personality disorder.
Zanarini MC
Curr Psychiatry Rep; 2004 Feb; 6(1):66-70. PubMed ID: 14738708
[TBL] [Abstract][Full Text] [Related]
18. Pharmacotherapy of the borderline patient: a critical review and clinical guidelines.
Kutcher SP; Blackwood DH
Can J Psychiatry; 1989 May; 34(4):347-53. PubMed ID: 2567621
[TBL] [Abstract][Full Text] [Related]
19. [The value of psychopharmacotherapy in the treatment of borderline personality disorder].
Leitner P; Serfling R
Psychiatr Prax; 1993 Nov; 20(6):207-10. PubMed ID: 7906044
[TBL] [Abstract][Full Text] [Related]
20. Practice guideline for the treatment of patients with borderline personality disorder. American Psychiatric Association.
American Psychiatric Association Practice Guidelines
Am J Psychiatry; 2001 Oct; 158(10 Suppl):1-52. PubMed ID: 11665545
[No Abstract] [Full Text] [Related]
[Next] [New Search]
